Author

Giorgia Bodini 1

1 University of Genoa

ABNORMAL INTRA-BOLUS PRESSURE CORRELATES WITH ESOPHAGO-GASTRIC DYSFUNCTION AND WITH INCREASING AGE - A STUDY USING HIGH-RESOLUTION MANOMETRY

Marco Della Coletta, Ottavia Bartolo, Francesca Galeazzi, Elisa Marabotto, Giorgia Bodini, Nicola de Bortoli, Manuele Furnari, Salvatore Tolone, Vincenzo Savarino, Edoardo Vincenzo Savarino

ADALIMUMAB IS MORE EFFECTIVE THAN AZATHIOPRINE AND MESALAMINE AT PREVENTING POSTOPERATIVE RECURRENCE OF CROHN’S DISEASE – A RANDOMIZED TRIAL

Edoardo Vincenzo Savarino, Giorgia Bodini, Pietro Dulbecco, Vincenzo Savarino, Vincenzo Savarino

ADALIMUMAB TROUGH LEVELS AND ANTI-ADALIMUMAB ANTIBODIES CORRELATE WITH CLINICAL AND ENDOSCOPIC ACTIVITY IN CROHN’S DISEASE PATIENTS.

Gaia Pellegatta, Sara Lo Pumo, Giorgia Bodini, Isabella Baldissarro, Edoardo G. Giannini, Vincenzo Savarino, Edoardo Vincenzo Savarino

BIOLOGICAL THERAPY IS ABLE TO HALT CROHN?S DISEASE PROGRESSION: A PROSPECTIVE, LONG TERM STUDY USING THE LÉMANN INDEX

Giorgia Bodini, Gaia Pellegatta, Edoardo G. Giannini, Vincenzo Savarino, Costanza De Maria, Isabella Baldissarro, Edoardo Vincenzo Savarino

Biological Therapy is Able to Halt Crohn's Disease Progression: a Prospective, Long Term Study Using the Lémann Index

Giorgia Bodini

BIOLOGICAL THERAPY IS ABLE TO MODIFY THE DISEASE PROGRESSION OF CROHN'S DISEASE PREVENTING ITS LONG-TERM ASSOCIATED DISABILITY - A STUDY PERFORMED USING THE LÈMANN SCORE

Giorgia Bodini

BIOLOGICAL THERAPY IS ABLE TO MODIFY THE DISEASE PROGRESSION OF CROHN’S DISEASE PREVENTING ITS LONG-TERM ASSOCIATED DISABILITY – A STUDY PERFORMED USING THE LÈMANN SCORE

Giorgia Bodini, Edoardo Giovanni Giannini, Vincenzo Savarino, Costanza De Maria, Laila Yehia, Isabella Baldissarro, Antonio Gasbarrini

CHANGES IN GASTRIC INTESTINAL METAPLASIA EXTENSION IN ANNUALLY-FOLLOWED-UP PATIENTS: 1-YEAR RESULTS OF A STUDY PERFORMED BY MEANS OF NARROW BAND IMAGING WITH MAGNIFICATION ENDOSCOPY.

Lorenzo Gemignani, Pietro Dulbecco, Elisa Giambruno, Giorgia Bodini, Manuele Furnari, Maria Giacchino, Fabio Gianiorio, Luca Mastracci, Federica Grillo, Francesca Sarocchi, Vincenzo Savarino

CORRELATION BETWEEN ADALIMUMAB TROUGH SERUM CONCENTRATION, ANTI-ADALIMUMAB ANTIBODIES AND TNF-Α LEVELS WITH CLINICAL OUTCOME IN PATIENTS AFFECTED BY CROHN’S DISEASE

Giorgia Bodini, Vincenzo Savarino, Pietro Dulbecco, Lorenzo Assandri, Edoardo Vincenzo Savarino, Vincenzo Savarino

CORRELATION BETWEEN EXTRA-INTESTINAL MANIFESTATIONS AND ANTI-DRUG ANTIBODIES DEVELOPMENT IN CROHN’S DISEASE PATIENTS.

Mattia Crespi, Giorgia Bodini, Edoardo G. Giannini, Vincenzo Savarino, Edoardo Vincenzo Savarino

Item 1 - 10 / 45
1
2 3 4 5